Dr Paula Cevaal is a post-doctoral scientist in the lab of Professor Sharon Lewin. She received her MSc training in The Netherlands, specialising in infectious diseases and immunology. She then spent a year doing youth advocacy work at AIDS2018, after which she completed a joint PhD in virology and nanomedicine. Her work focuses on developing non-viral vectors to efficiently deliver therapeutics to primary CD4+ T cells. Specifically, she led a new line of research pioneering lipid nanoparticles for the delivery of mRNA-based latency-reversing agents to the latent HIV reservoir. The overarching goal of her work is to take gene editing-related strategies to the clinic.
